Fundraising Fox
Matthew R. Patterson
InvestorFounderVenture Partner at SR One Capital Management · Founder at Audentes Therapeutics
San Francisco Bay Area
FoundedAudentes Therapeutics
Find your path to Matthew
Sign up to see every warm intro you have to Matthew
- Paths you didn't know you had: your email and LinkedIn already hold routes to Matthew. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Matt Patterson is a Venture Partner at SR One Capital Management with over 30 years in the research, development, and commercialization of therapeutics. He co-founded Audentes Therapeutics in 2012 and served as CEO until its 2020 acquisition by Astellas Pharma, and previously worked at Genzyme, BioMarin Pharmaceutical, Amicus Therapeutics, and Iris Medicine, as well as serving as an Entrepreneur-In-Residence at OrbiMed. He holds a Bachelor's degree in Biochemistry from Bowdoin College.
Contact· self-published, not guessed
Likely email· guessed from name + firm domain, not firm-published
- m•••@srone.comreveal100% confident
Invests in
Biotech
Founder at Audentes Therapeutics
Intro paths
In turn, Matthew can intro founders to Audentes Therapeutics's investors below.
Audentes Therapeutics's investors · 7
Investments
Board seats
Addition TherapeuticsAddition TherapeuticsRemix Therapeutics, IncRemix Therapeutics, Inc.Rezo Therapeutics Inc.Vor Biopharma, Inc.
Sources: the firm's website · SEC Form D filings.
Colleagues at SR One Capital Management
Frequently asked questions
- Who is Matthew R. Patterson?
- Matt Patterson is a Venture Partner at SR One Capital Management with over 30 years in the research, development, and commercialization of therapeutics. He co-founded Audentes Therapeutics in 2012 and served as CEO until its 2020 acquisition by Astellas Pharma, and previously worked at Genzyme, BioMarin Pharmaceutical, Amicus Therapeutics, and Iris Medicine, as well as serving as an Entrepreneur-In-Residence at OrbiMed. He holds a Bachelor's degree in Biochemistry from Bowdoin College.
- Where does Matthew R. Patterson work?
- Matthew R. Patterson is Founder of Audentes Therapeutics and Venture Partner at SR One Capital Management.
- What does Matthew R. Patterson invest in?
- Matthew R. Patterson invests in Biotech.
- What companies did Matthew R. Patterson found?
- Matthew R. Patterson founded Audentes Therapeutics.
- What boards does Matthew R. Patterson sit on?
- Matthew R. Patterson holds tracked board seats at Addition Therapeutics, Addition Therapeutics, Remix Therapeutics, Inc, Remix Therapeutics, Inc., Rezo Therapeutics Inc., Vor Biopharma, Inc..
Founder mafias
Bowdoin College mafia32
Also came through, then founded or led a company.
OrbiMed mafia14
Also came through, then founded or led a company.
Audentes Therapeutics mafia7
Also came through, then founded or led a company.
SR One Capital Management mafia6
Also came through, then founded or led a company.
Amicus Therapeutics mafia4
Also came through, then founded or led a company.
About this profile. Compiled from public sources — SR One Capital Management's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights